Sign in
4

Changes in Ownership

IONIS PHARMACEUTICALS INC Filed Acc 0000874015-25-000218

EVP, Chief Development Officer sold 10,000 shares at $50.37 ($503,671)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Geary Richard S · EVP, Chief Development Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2025-09-02 Sale : show line 1 in the form 10b5-1 −10,000 $50.37 $503,671 79,657 D
Open-market sales · 10,000 sh · avg $50.37 · $503,671
Loading xslF345X05/edgardoc.xml…